168 related articles for article (PubMed ID: 18568558)
41. Prevention of Contrast-induced Nephropathy in Patients Undergoing Percutaneous Coronary Intervention.
Pranata R; Wahyudi DP
Curr Cardiol Rev; 2023 Oct; 20(1):. PubMed ID: 37877506
[TBL] [Abstract][Full Text] [Related]
42. Predictive Value of Lymphocyte-to-monocyte Ratio in Patients with Contrast-induced Nephropathy After Percutaneous Coronary Intervention for Acute Coronary Syndrome.
Karauzum I; Karauzum K; Acar B; Hanci K; Bildirici HIU; Kilic T; Ural E
J Transl Int Med; 2021 Jun; 9(2):123-130. PubMed ID: 34497751
[TBL] [Abstract][Full Text] [Related]
43. Contrast medium-induced nephropathy. Aspects on incidence, consequences, risk factors and prevention.
Sterner G; Nyman U
Libyan J Med; 2007 Sep; 2(3):118-24. PubMed ID: 21503209
[TBL] [Abstract][Full Text] [Related]
44. Risk Prediction for Contrast-Induced Nephropathy in Cancer Patients Undergoing Computed Tomography under Preventive Measures.
Jeon J; Kim S; Yoo H; Kim K; Kim Y; Park S; Jang HR; Kim DK; Huh W; Kim YG; Kim DJ; Oh HY; Lee JE
J Oncol; 2019; 2019():8736163. PubMed ID: 31057617
[TBL] [Abstract][Full Text] [Related]
45. Assessing the Risk of Contrast-Induced Nephropathy Using a Finger Stick Analysis in Recalls from Breast Screening: The CINFIBS Explorative Study.
Houben IPL; van Berlo CJLY; Bekers O; Nijssen EC; Lobbes MBI; Wildberger JE
Contrast Media Mol Imaging; 2017; 2017():5670384. PubMed ID: 29097928
[TBL] [Abstract][Full Text] [Related]
46. Contrast-induced nephropathy in urological imaging: A comparison with cardiology interventions.
Babu M; Bansal D; Mehta SB; Pillai B; Krishnamoorthy H; Attacharil T
Indian J Urol; 2017; 33(3):241-245. PubMed ID: 28717277
[TBL] [Abstract][Full Text] [Related]
47. Sodium bicarbonate prophylactic therapy in the prevention of contrast-induced nephropathy in patients admitted to the intensive care unit of a teaching hospital: a retrospective cohort study.
Lefel N; Janssen L; le Noble J; Foudraine N
J Intensive Care; 2016; 4():5. PubMed ID: 26759720
[TBL] [Abstract][Full Text] [Related]
48. Contrast Dose, Estimated GFR, and Techniques to Reduce Contrast Dose in PCI - Time to Consider Some Basic Principles!
Nyman U
J Invasive Cardiol; 2016 Oct; 28(10):E126-E127. PubMed ID: 27705897
[No Abstract] [Full Text] [Related]
49. Albuminuria Pre-Emptively Identifies Cardiac Patients at Risk of Contrast-Induced Nephropathy.
Vicente-Vicente L; Casanova AG; Hernández-Sánchez MT; Prieto M; Martínez-Salgado C; López-Hernández FJ; Cruz-González I; Morales AI
J Clin Med; 2021 Oct; 10(21):. PubMed ID: 34768464
[TBL] [Abstract][Full Text] [Related]
50. A Simplified Risk Score to Estimate the Risk of Contrast-Induced Nephropathy after Contrast Exposure.
Kulkarni CS; Kothari JP; Sirsat RA; Almeida AF
Indian J Nephrol; 2023; 33(5):333-339. PubMed ID: 37881743
[TBL] [Abstract][Full Text] [Related]
51. A Simple Strategy to Reduce Contrast Media Use and Risk of Contrast-Induced Renal Injury during PCI: Introduction of an "Optimal Contrast Volume Protocol" to Daily Clinical Practice.
Zebrauskaite A; Ziubryte G; Mackus L; Lieponyte A; Kairyte E; Unikas R; Jarusevicius G
J Cardiovasc Dev Dis; 2023 Sep; 10(9):. PubMed ID: 37754831
[TBL] [Abstract][Full Text] [Related]
52. The molecular mechanism of contrast-induced nephropathy (CIN) and its link to in vitro studies on iodinated contrast media (CM).
Yang JS; Peng YR; Tsai SC; Tyan YS; Lu CC; Chiu HY; Chiu YJ; Kuo SC; Tsai YF; Lin PC; Tsai FJ
Biomedicine (Taipei); 2018 Mar; 8(1):1. PubMed ID: 29480796
[TBL] [Abstract][Full Text] [Related]
53. Correction: Absolute and relative GFR and contrast medium dose/GFR ratio: cornerstones when predicting the risk of acute kidney injury.
Nyman U; Leander P; Liss P; Sterner G; Brismar T
Eur Radiol; 2024 Mar; 34(3):2123-2124. PubMed ID: 37668696
[No Abstract] [Full Text] [Related]
54. Correction to: Absolute and relative GFR and contrast medium dose/GFR ratio: cornerstones when predicting the risk of acute kidney injury.
Nyman U; Leander P; Liss P; Sterner G; Brismar T
Eur Radiol; 2024 May; 34(5):3526. PubMed ID: 37851122
[No Abstract] [Full Text] [Related]
55. Renal function-based contrast dosing to define safe limits of radiographic contrast media in patients undergoing percutaneous coronary interventions.
Gurm HS; Dixon SR; Smith DE; Share D; Lalonde T; Greenbaum A; Moscucci M;
J Am Coll Cardiol; 2011 Aug; 58(9):907-14. PubMed ID: 21851878
[TBL] [Abstract][Full Text] [Related]
56. The contrast medium volume to estimated glomerular filtration rate ratio as a predictor of contrast-induced nephropathy after primary percutaneous coronary intervention.
Liu Y; Tan N; Zhou YL; He PC; Luo JF; Chen JY
Int Urol Nephrol; 2012 Feb; 44(1):221-9. PubMed ID: 21336957
[TBL] [Abstract][Full Text] [Related]
57. Contrast media-induced nephropathy in Tunisia: prospective case-control study with cardio-nephrological monitoring.
Hajji M; Jebali H; Chaabouni E; Mzoughi K; Zairi I; Kraiem S; Raies L; Hamida FB; Fatma LB; Zouaghi MK; Abdallah TB
Pan Afr Med J; 2023; 45():144. PubMed ID: 37808435
[TBL] [Abstract][Full Text] [Related]
58. Absolute and relative GFR and contrast medium dose/GFR ratio: cornerstones when predicting the risk of acute kidney injury.
Nyman U; Leander P; Liss P; Sterner G; Brismar T
Eur Radiol; 2024 Jan; 34(1):612-621. PubMed ID: 37540321
[TBL] [Abstract][Full Text] [Related]
59. Endovascular Treatment Using a Small Amount of Contrast Medium in a Patient with a Posterior Communicating Artery Ruptured Dissecting Aneurysm and Chronic Kidney Disease: A Case Report.
Yasuda H; Nagamitsu S; Kaneko N; Nagatsuna T; Urakawa M; Fujii M; Yamashita T; Okamoto S
J Neuroendovasc Ther; 2022; 16(6):301-306. PubMed ID: 37501891
[TBL] [Abstract][Full Text] [Related]
60. Strategies for Renal Protection in Cardiovascular Interventions.
Ali ZA; Escaned J; Dudek D; Radhakrishnan J; Karimi Galougahi K
Korean Circ J; 2022 Jul; 52(7):485-495. PubMed ID: 35790493
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
